SHANGHAI HENGRUI PHARMACEUTICAL CO. LTD.;JIANGSU HENGRUI MEDICINE CO. LTD.
发明人:
申请号：
EP11816055.5
公开号：
EP2604612B1
申请日:
2011.06.30
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
Disclosed are C-aryl glucoside derivatives, preparation processes and pharmaceutical uses thereof, especially C-aryl glucoside derivatives represented by formula (I), pharmaceutical salts or all stereoisomers thereof, their preparation methods, pharmaceutical compositions containing the derivatives and their uses as therapeutic agents, especially as sodium-dependent glucose cotransporter(SGLT)-1 inhibitors, wherein each substituent of formula (I) is defined in the specification.
